Status:
COMPLETED
Improving Medication Adherence in the Alabama Black Belt
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
University of Alabama at Birmingham
Conditions:
Diabetes Mellitus
Medication Adherence
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Medication adherence is especially critical in regions like rural Alabama, where residents have among the worst health outcomes in the US. This project was designed in collaboration with our community...
Detailed Description
Improving medication adherence is one of the greatest challenges in modern medicine. Despite decades of research on the topic, as many as half of patients with chronic diseases are not taking medicati...
Eligibility Criteria
Inclusion
- adults
- type 2 diabetes
- taking medications for diabetes
- medication non adherent
Exclusion
- nursing home residence
- plans to move away in the next year
- advanced illnesses such as hemodialysis, cancer or dementia
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2019
Estimated Enrollment :
473 Patients enrolled
Trial Details
Trial ID
NCT02274844
Start Date
April 1 2016
End Date
January 31 2019
Last Update
October 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of Alabama at Birmingham
Birmingham, Alabama, United States, 35210